Geniant Cranial (Navigated Neurosurgical Positioning Robot)
Koh Young Technology, Inc. · Decision date Sep 10, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 10, 2026 for K253856, Geniant Cranial (Navigated Neurosurgical Positioning Robot), submitted by Koh Young Technology, Inc. The submission is a traditional 510(k) under 21 CFR 882.4560, product code HAW, in the Neurology panel; the public database lists receipt on December 3, 2025, while the clearance letter cites June 12, 2026 dates. SESE is a clearance to market, not a PMA approval.
The cleared item is the Geniant Cranial software version V3.2, described as a hardware platform supporting real-time surgical navigation from preoperatively acquired CT or MR images, with a console and optical sensor plus a robot stand with robotic arm and patient positioning module. The 510(k) summary names the prior Geniant Cranial clearance K241333 as predicate and states that other system functions, intended use and safety features are unchanged. The summary does not specify which software changes were made, so the technical scope of the modification remains unknown from these excerpts.
The indications describe aid in locating anatomical structures and positioning instrument holders or tool guides for neurosurgeons in open or percutaneous procedures where stereotactic surgery is appropriate and a rigid structure such as the skull can be referenced to images. The summary also lists a secondary classification, neurosurgical skull clamp (882.4460, HBL). No clinical performance data are reported in the available excerpts.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Sep 10, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K253856
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Koh Young Technology, Inc.
- Product code
- HAW
- Decision code
- SESE
- Decision date
- Sep 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Neurological Stereotaxic Instrument.
- Applicant
- Koh Young Technology, Inc.
- Product code
- HAW
- FDA device class
- 2
FDA decision timeline
K253856 received
Application receipt date recorded by FDA.
K253856 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HAW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| inomed Medizintechnik GmbH | 510(k) clearance | Nov 6, 2026 | FDA | |
| Medtronic Navigation | 510(k) clearance | Nov 6, 2026 | FDA | |
NeuroAlignK261997 | Medivis, Inc. | 510(k) clearance | Oct 26, 2026 | FDA |
| Guangzhou Aimooe Technology Co., Ltd. | 510(k) clearance | Oct 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Koh Young Technology, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Yeoju
Sources and methodology
- Original FDA record: K253856
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

